1.Relationship Between ADHD Symptoms and Multidimensional Obesity Phenotypes in School-Aged Children: The Potential Mediating Role of Unhealthy Eating Behaviors
Zengzhen ZHANG ; Ting NING ; Weixi DENG ; Xinyi ZHENG ; Wenqi XIA ; Fengyan CHEN ; Yaling ZOU ; Jianduan ZHANG
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2026;55(5):659-665
Objective To explore the association between attention-deficit/hyperactivity disorder (ADHD) symptoms and multidimensional obesity phenotypes defined by BMI and body composition indicators in school-aged children, and further analyze the potential mediating role of unhealthy eating behaviors. Methods A cross-sectional study was conducted among 6624 children aged 6–18 years from Zhuhai, China, recruited via stratified cluster sampling in 2023. Height and weight were measured to calculate BMI, and body composition indicators, including body fat percentage and waist-to-hip ratio, were assessed by bioelectrical impedance analysis. ADHD symptoms were evaluated with the parent-rated Swanson Nolan and Pelham-Ⅳ (SNAP-Ⅳ), while eating behaviors were assessed with the children's self-reported Dutch Eating Behavior Questionnaire. Four obesity phenotypes were defined:obesity by BMI;obesity with a high waist-to-hip ratio;obesity with high body fat percentage; and obesity with high trunk fat percentage. Multilevel logistic regression was performed for association analysis, and mediation effects were tested using the bootstrap method. Results The positive screening rate for ADHD symptoms was 6.9%, and the detection rate of obesity was 10.3%. Among all participants,hyperactive-impulsive symptom scores were positively associated with obesity (OR=1.31) and obesity with a high waist-to-hip ratio (OR=1.31). Among girls, these scores were also significantly positively associated with obesity with high body fat percentage (OR=1.40) and obesity with high trunk fat percentage (OR=1.38),whereas no significant associations of these indicators were found in boys. Restrained eating scores showed a potential mediating effect in these associations, explaining 61.0%-72.2% of the total effect in the overall sample and 35.9%-39.1% in girls. Conclusion ADHD symptoms in school-aged children are associated not only with the risk of obesity but also with multidimensional obesity phenotypes characterized by central fat accumulation. Restrained eating may be an important potential mediator in this association. For obesity prevention and control, attention should be paid to children with hyperactive-impulsive symptoms and their eating behaviors. Body composition indicators may facilitate refined phenotyping, yet their value in routine monitoring requires validation in prospective studies.
2.Research progress on the clinical application of remazolam
Fengyan YANG ; Yue ZHANG ; Enxian CHEN ; Xuerong MIAO ; Kai WEI
Journal of Pharmaceutical Practice and Service 2024;42(9):365-374
Remazolam is a new ultra-short-acting benzodiazepine that produces sedation by acting on γ-aminobutyric acid type A(GABAA)receptors.Remazolam has characteristics of rapid onset of action,short half-life,high clearance,and no accumulation in the body.It also has a low incidence of injection pain and mild effects on hepatic and renal function,respiration,and haemodynamics.Additionally,it can be rapidly reversed by flumazenil.The clinical research progress on remazolam in the areas of procedural sedation,induction,and maintenance of general anesthesia were reviewed to provide references for its clinical application.
3.Clinical features and Y chromosome abnormalities in children with 45, X/46, XY mosaicism
Junke XIA ; Chen CHEN ; Yaqin HOU ; Fengyan TIAN ; Xiangdong KONG
Chinese Journal of Pediatrics 2024;62(2):165-169
Objective:To investigate the clinical and genetic characteristics of children with 45, X/46, XY mosaicism.Methods:The retrospective study included 20 children diagnosed with 45, X/46, XY and 45, X/46, X,+mar mosaicism in the First Affiliated Hospital of Zhengzhou University from 2018 to 2022. The clinical features, gonadal pathology, treatment and follow-up were summarized. Genetic tests were performed by SRY gene test, azoospermia factor region (AZF) deletion test, copy number variation-sequencing (CNV-seq). Age at first diagnosis was compared between boys and girls using independent sample t-test. Results:The 20 patients included 3 boys and 17 girls, and the age at first diagnosis were (7.6±5.5) years, it is (2.1±1.9) years in boys, (8.7±5.4) years in girls, significantly younger for boys ( t=-3.86, P=0.004). The chief complaint was external genitalia malformation for boys, and short stature (13 cases) and dysplastic external genital for girls (4 cases). Five girls presented with features of Turner syndrome. The gonadal phenotypes included mixed gonadal dysplasia (MGD, 6 cases), complete gonadal dysplasia (CGD, 10 cases), unilateral ovotestis (2 cases), possible ovaries (1 case) and undetermined gonad (1 case). One female with dysplastic genital was reassigned to male, and the gender of the remaining cases remained unchanged. Seven females were treated with recombinant human growth hormone. The height increased by (17±7) cm during the (2.9±1.2) years follow-up. No gonadal malignancy was observed. The karyotype was 45, X/46, XY in 16 cases, and 45, X/46, X,+mar in 4 cases. All of the 4 marker chromosomes were derived from Y chromosome confirmed by CNV-seq. SRY gene was detected in all 20 patients genome, and AZF deletion was found in 7 girls. Conclusions:45, X/46, XY mosaicism presented with dysplastic external genital or female with remarkable short stature. Gonadal phenotypes included MGD, CGD and ovotestis. AZF microdeletions were found in the majority of female cases.
4.Comparative analysis of CT features of gastrointestinal stromal tumors,neurogenic tumors and leiomyomas in stomach
Yue LI ; Guihan YANG ; Weichao YANG ; Fengyan CHENG ; Yulin LIN ; Chun YAO ; Xiaofeng CHEN ; Zhiqi YANG
Journal of Practical Radiology 2024;40(8):1296-1299,1333
Objective To investigate the difference of CT features of gastrointestinal stromal tumors(GIST),neurogenic tumors,and leiomyomas in stomach.Methods A retrospective analysis was performed on clinical and CT features from 312 cases of GIST,21 cases of neurogenic tumors,and 35 cases of leiomyomas in stomach.Results GIST were most commonly found in the body of stomach and exhibited large tumor sizes and late onset.CT showed GIST predominantly showed intraluminal and mixed growth pattern with irregular or round shapes and uneven density,and cystic degeneration and calcification were frequently observed.The CT values of GIST in the arterial phase and the degree of arterial enhancement were higher,with light to moderate arterial phase enhancement and moderate to marked venous phase enhancement.Gastric leiomyomas had smaller tumor sizes and presented mainly in the cardia,gastric fundus,and lesser curvature of gastric body.CT showed the intraluminal growth pattern,primarily in round shapes with uniform density,lower incidence of cystic degeneration and calcification,both the arterial and venous phase CT values and the extent of enhancement in these phases were lower,showed no or slight enhancement during the arterial phase and light to moderate enhancement during the venous phase.Gastric neurogenic tumors were predominantly located in the gastric body and antrum.CT showed the tumors demonstrated extraluminal and mixed growth patterns,most with oval-shaped appearace,uniform density and the venous phase CT values and the degree of enhancement were higher,with light to moderate arterial enhancement and moderate to marked venous enhancement.Conclusion GIST,neurogenic tumors,and leiomyomas in stomach can be differentiated based on their distinct CT features.Accurate recognition of these features aids in the differential diagnosis of these kinds of tumors.
5.Clinical effect of trapezoidal transparent corneal incision during phacoemulsi-fication
Chaofeng YUAN ; Fei CHEN ; Wenna GAO ; Chengxia MA ; Xiaohua ZHAO ; Ling ZHANG ; Fengyan ZHANG
Recent Advances in Ophthalmology 2024;44(8):619-622
Objective To explore the clinical effect of a trapezoidal transparent corneal incision during phacoemulsi-fication.Methods A total of 57 patients(68 eyes)undergoing phacoemulsification were selected and divided into a con-ventional incision group and a trapezoidal incision group using a random number table method.There were 28 patients(34 eyes)in the conventional incision group,including 15 eyes(males)and 19 eyes(females),with an age range of 41-82(65.0±10.1)years;and there were 29 patients(34 eyes)in the trapezoidal incision group,including 21 eyes(males)and 13 eyes(females),with an age range of 46-87(66.0±11.1)years.All patients underwent cataract phacoemulsification combined with intraocular lens(IOL)implantation.A 3.0 mm transparent corneal incision was made for patients in the conventional incision group,while an improved trapezoidal transparent corneal incision was made for patients in the trape-zoidal incision group.The uncorrected visual acuity,intraocular pressure,corneal astigmatism,and incidence of intraoper-ative and postoperative complications were compared between the two groups.Results The uncorrected visual acuity of patients in the trapezoidal incision group was better than that of patients in the conventional incision group at 1 week and 3 months after surgery,and the differences were statistically significant(both P<0.05).There was no statistically significant difference in intraocular pressure and corneal astigmatism between the two groups of patients at 1 week,1 month,and 3 months after surgery(all P>0.05).The number of eyes with anterior chamber collapse and the number of eyes requiring a watertight incision in the conventional incision group were greater than those in the trapezoidal incision group during sur-gery,and the differences were statistically significant(both P<0.05).The number of eyes with incision edema and the number of eyes with incision gap in the conventional incision group were greater than those in the trapezoidal incision group after surgery,and the differences were statistically significant(both P<0.05).In the conventional incision group,IOL was displaced in 18 eyes due to the shallow anterior chamber and then returned to normal after the formation of the anterior chamber through a watertight incision during surgery;during the formation,iris prolapse and incarceration occurred in 2 eyes,and IOL rotation or incarceration occurred in 3 eyes.In the trapezoidal incision group,3 eyes had a shallow anterior chamber after surgery,and a watertight incision was used to form the anterior chamber;there was no IOL incarceration or displacement or iris prolapse.Conclusion The improved trapezoidal transparent corneal incision can effectively prevent IOL displacement caused by anterior chamber collapse during cataract surgery while ensuring the stability of the anterior chamber.It can also reduce the related complications caused by the watertight incision using a flushing needle and restore patients'vision as early as possible.
6. Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients
Xuelian LIU ; Peiyu YANG ; Xiaoyuan YU ; Jingcheng CHEN ; Xiaoliang LIU ; Jing BAI ; Yingmin LIU ; Hua HE ; Jingnan SUN ; Hongqiong FAN ; Chen ZHANG ; Ye ZHANG ; Keju SU ; Chunshui LIU ; Yehui TAN ; Sujun GAO ; Wei LI ; Fengyan JIN
Chinese Journal of Hematology 2018;39(5):408-413
Objective:
To investigate the effect of 1q21 amplification (1q) on the therapeutic response and prognosis of bortezomib(Btz) in the treatment of newly diagnosed multiple myeloma (MM) patients.
Methods:
A total of 180 newly diagnosed MM were included for analyses of clinical characteristics, cytogenetics, objective response rate (ORR), progression-free survival (PFS) and overall survival (OS), retrospectively. Gene expression profiling (GEP) was analyzed using publicly available R2 platform.
Results:
① In 180 patients, 1q was found in 51.1% cases. Of them, 174 patients had complete follow-up data, including 88 cases with 1q and 86 without 1q (non-1q). ②Incidence of 1q was positively associated with percentage of IGH rearrangement (72.2%,
7.Comparison between EUS-guided ethanol ablation and surgical treatment of benign insulinoma
Yanjuan JIANG ; Shanyu QIN ; Haixing JIANG ; Fengyan QIN ; Zhiling LIU ; Zuojie LUO ; Yingfen QIN ; Jia ZHOU ; Yuzhen LIANG ; Min LIANG ; Xinghuan LIANG ; Junqiang CHEN ; Xingan QIN
China Journal of Endoscopy 2017;23(4):8-13
Objective To evaluate the safety and efficacy of endoscopic ultrasound (EUS) guided ethanol ablation of benign insulinoma and compare its' advantages and disadvantages with surgical treatment. Methods From April 2011 to February 2016, clinical data of 38 patients with benign insulinoma treated by EUS-guided ethanol ablation or surgical treatment were retrospectively analyzed. Results 97.4% (37/38) patients had a typical clinical manifestation of Whipple's triad, and the I/G ratio of 82.9% patients (29/35) was more than 0.3 with their onset of hypoglycemia. The positive preoperative etiologic diagnosis rates of transabdominal ultrasonography, CT, MRI, PET/CT and EUS were 50.0%, 67.6%, 66.7%, 75.0%, 89.7% respectively. In the current study, 18 patients underwent EUS-guided ethanol ablation (EUS-FNI group) and 20 patients received surgicaltreatment (surgical group). Compared with the surgical group, the operation time, intraoperative hemorrhage volume, postoperative complications, length of stay and hospitalization costs were significantly reduced in the EUS-FNI group (P < 0.05). No treatment-related complications was observed in EUS-FNI group, while 40.0% (8/20) patients in surgical group had complications. During the follow-up period, all these patients maintained stable blood glucose without taking medication, and there's no recurrence of insulinoma in EUS-FNI group after the last treatment with alcohol injection; In surgical group, only 90.0% (18/20) patients had no recurrence, episode of hypoglycemia was less after the operation in 10.0% (2/20) patients. Conclusion EUS-guided ethanol ablation of benign insulinoma is safe and effective, compared with traditional surgical treatment, EUS-guided ethanol ablation is minimally invasive, costs less, recovers fast after treatment and has fewer complications.
8.Clinical effectiveness of 1540nm non-ablative erbium laser in treatment of xanthelasma palpebrarum
Chunyuan LUO ; Can WANG ; Guorui CHEN ; Fengyan LIU
Chinese Journal of Medical Aesthetics and Cosmetology 2017;23(6):406-408
Objective Xanthelasma palpebrarum presents a therapeutic and aesthetic challenge because of its high visibility and frequent rate of recurrence with a wide variety of treatments.Many patients were disappointed by an initial unsuccessful treatment and fail to return for further therapy until the problem had become quite conspicuous.So a simple treatment with few side effects and good acceptance remains an important goal.Methods Eleven patients with xanthelasma lesions were treated with the 1540nm erbium:glass laser.We could see erythema and swell around the skin lesion immediately.It needed irradiate again after one month if there was residual lesion.The end point was the lesions completely removed.The therapeutic effect of 1540nm erbium laser,the adverse reaction and the satisfaction of patients were observed.Results All lesions were removed without hyperpigmentation or scarring.Conclusions The 1540 nm erbium:glass laser represents an effective means for treating xanthelasmas with few side effects and good acceptance.
9. A retrospective study of the BiRd regimen in the treatment of relapsed/ refractory multiple myeloma
Xuelian LIU ; Lu LI ; Qinglin SHI ; Lijuan CHEN ; Xinxin CAO ; Jian LI ; Aijun LIAO ; Dehui ZOU ; Jingnan SUN ; Sujun GAO ; Wei LI ; Jian HOU ; Fengyan JIN
Chinese Journal of Hematology 2017;38(10):837-841
Objective:
To evaluate efficacy of the BiRd regimen, a combination of clarithromycin, lenalidomide, and dexamethasone, in the treatment of patients with relapsed/refractory multiple myeloma (RRMM) .
Methods:
Patients with RRMM treated with BiRd between September 11, 2013 and August 1, 2016 at six centers were included to evaluate overall survival rate (ORR) , clinical benefit rate (CBR) , progression-free survival (PFS) , overall survival (OS) , as well as adverse events.
Results:
Of 30 patients with RRMM, 27 patients were evaluable, and ORR and CBR were 51.9% (14/27) and 66.7% (18/27) respectively, including 1 sCR (3.7%) , 3 CR (11.1%) , 3 VGPR (11.1%) , and 7 PR (25.6%) . In 13 patients with prior Rd, ORR and CBR were 38.5% (5/13) and 61.5% (8/13) respectively, of which 5 patients with ≥MR carried high-risk cytogenetic[ (e.g.17p- or t (4;14) ] together with at least one of other adverse-prognostic cytogenetic (e.g.13q- and/or 1q21+) . In 24 patients with prior bortezomib-based therapy, ORR and CBR were 45.8 and 62.5%, respectively. With a median follow-up time of 14.9 (range 1.0-33.8) months, the median PFS and OS were 12.0 (95%
10.A prospective multi-center trial of non-interventional and observational study of lenalidomide in Chinese patients with multiple myeloma
Guomiao WANG ; Guangzhong YANG ; Zhongxia HUANG ; Yuping ZHONG ; Fengyan JIN ; Aijun LIAO ; Xiaomin WANG ; Zhengzheng FU ; Hui LIU ; Xiaolin LI ; Jianfeng ZHOU ; Xi ZHANG ; Yu HU ; Fanyi MENG ; Xiaojun HUANG ; Wenming CHEN ; Jin LU
Chinese Journal of Internal Medicine 2017;56(7):500-506
Objective To evaluate the efficacy and safety of lenalidomide in a real-world clinical practice in Chinese patients with multiple myeloma (MM).Methods It was a prospective,multi-center,observational study.A total of 165 consecutive patients with MM treated with lenalidomide-based regimens were enrolled in 12 hospitals from June 2013 to November 2015.Relevant information was recorded,such as baseline clinical data,cytogenetic abnormalities,treatment regimens,and duration of treatment,safety,and survival.Results (1)There were 126 relapsed and refractory MM (RRMM) patients,25 newly diagnosed patients and 19 maintenance patients.The evaluable RRMM patients accounted for 120 cases,among which 74 cases(61.7%) reached the partial response (PR) or above,and a very good partial response (VGPR) in 16 patients (13.3%),a complete response (CR) in 14 cases (11.7%),a strictly complete response (sCR) in 4 cases (3.3%).Thus,a VGPR or above in 34 patients accounted for 28.3%.(2)The median follow-up was 13 months,the median time to progression 12 months.The median survival after receiving lenalidomide was 19 months,and the median overall survival (OS) was 62 months.(3) The univariate analysis in 120 RRMM patients suggested that prognostic factors for significant improvement in PFS included normal karyotype,international staging system (ISS) Ⅰ-Ⅱ,t(4;14) negative (detected by fluorescence in situ hybridization),non-bortezomib resistance and response to previous regimens.As to OS,nonbortezomib resistance,response to previous regimens and non-primary refractoriness were positive factors.Multivariate analysis showed that the response to previous regimens (PR or better) was an independent good prognostic factor for progress-free survival (PFS),non-bortezomib resistance and non-primary refractoriness for OS.(4) Grade 3 or 4 adverse events that occurred in more than 10% of all enrolled patients were neutropenia (12.7%),leukocytosis (11.5%) and thrombocytopenia (12.7%).Owing to intolerance of toxic side effects,7 cases withdrew lenalidomide.Conclusions No matter what combination,regimens containing lenalidomide are effective to RRMM patients with overall response rate 61.7%,a time to progression 12 months and an overall survival 62 months.The toxicity is quite tolerable and manageable.In addition,the response to previous treatment (reached PR or above) is the independent good prognostic factor for PFS,non-bortezomib resistance and non-primary refractoriness for OS.Clinical trail registration Clinicaltrials.gov,NCT01947309


Result Analysis
Print
Save
E-mail